| Financial Year |
March 31 2023 |
| Monetary Funds |
2,447,104,844.16 |
| Held-for-trading Financial Assets |
1,529,309.91 |
| Notes Receivable |
-- |
| Accounts Receivable |
339,444,897.12 |
| Advances to Suppliers |
58,731,213.17 |
| Other Receivables |
31,844,112.40 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
790,157,317.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
78,518,645.10 |
| Total Current Assets |
3,748,849,840.21 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,402,382,615.35 |
| Under-construction Projects |
187,608,624.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
232,456,352.90 |
| R&D expenses |
-- |
| Goodwill |
215,736,108.78 |
| Long-Term Deferred and Prepaid Expenses |
10,909,870.17 |
| Deferred Income Tax Assets |
95,991,792.30 |
| Other Non-Current Assets |
868,364,667.75 |
| Sub-Total of Non-Current Assets |
3,068,403,542.00 |
| Total Assets |
6,817,253,382.21 |
| Short-Term Loans |
1,266,399,526.68 |
| Trading Financial liabilities |
214,800.00 |
| Notes Payable |
196,783,257.98 |
| Accounts Payable |
324,115,639.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,697,534.44 |
| Taxes Payable |
45,635,690.28 |
| Interest Payable |
-- |
| Dividend Payable |
109,241.16 |
| Other payables |
63,602,376.75 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
140,547,224.63 |
| Other Current Liabilities |
1,993,657.65 |
| Sub-Total of Current Liabilities |
2,143,887,567.30 |
| Long-term Loans |
526,770,163.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
25,726,168.10 |
| Deferred Income Tax Liabilities |
41,437,238.58 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
673,456,380.88 |
| Total Liabilities |
2,817,343,948.18 |
| Paid-In Capital(Or Share Stock) |
384,226,985.00 |
| Capital Surplus |
2,291,698,390.17 |
| Surplus Reserve |
161,556,882.78 |
| LESS:Treasury Stock |
51,569,889.27 |
| Undistributed Profits |
1,265,474,763.45 |
| Minority Stockholder's Interest |
320,647.67 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,999,588,786.36 |
| Owner's Equity（Stockholder's Equity） |
3,999,909,434.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,817,253,382.21 |
